Noninvasive monitoring of pharmacodynamics and kinetics of a death receptor 5 antibody and its enhanced apoptosis induction in sequential application with doxorubicin

Noninvasive monitoring of pharmacodynamics and kinetics of a death receptor 5 antibody and its enhanced apoptosis induction in sequential application with doxorubicin

Item
http://www.wikidata.org/entity/Q37061007
Glycoengineering of therapeutic antibodies enhances monocyte/macrophage-mediated phagocytosis and cytotoxicityApoptosis imaging for monitoring DR5 antibody accumulation and pharmacodynamics in brain tumors noninvasively.Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates.Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor model.Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivativeCancer subclonal genetic architecture as a key to personalized medicine.Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application scheduleThe role of the TNF receptors and apoptosis inducing ligands in tumor growth.
P2860

Noninvasive monitoring of pharmacodynamics and kinetics of a death receptor 5 antibody and its enhanced apoptosis induction in sequential application with doxorubicin

Item
http://www.wikidata.org/entity/Q37061007
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Noninvasive monitoring of phar ...... l application with doxorubicin
@en
Noninvasive monitoring of phar ...... application with doxorubicin.
@nl
type
label
Noninvasive monitoring of phar ...... l application with doxorubicin
@en
Noninvasive monitoring of phar ...... application with doxorubicin.
@nl
prefLabel
Noninvasive monitoring of phar ...... l application with doxorubicin
@en
Noninvasive monitoring of phar ...... application with doxorubicin.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Noninvasive monitoring of phar ...... l application with doxorubicin
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932